Contraceptive Market by Drugs (Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives), Gender (Female Contraceptive Devices, Male Contraceptive Devices), Distribution - Global Forecast 2023-2030

Contraceptive Market by Drugs (Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives), Gender (Female Contraceptive Devices, Male Contraceptive Devices), Distribution - Global Forecast 2023-2030

The Contraceptive Market is projected to reach USD 255.58 billion by 2030 from USD 62.03 billion in 2022, at a CAGR of 19.36% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Contraceptive Market.

• Based on Drugs, market is studied across Contraceptive Injectable, Emergency Contraceptive Pills, Oral Contraceptives, and Transdermal Patches. The Emergency Contraceptive Pills is projected to witness significant market share during forecast period.
• Based on Gender, market is studied across Female Contraceptive Devices and Male Contraceptive Devices. The Male Contraceptive Devices is projected to witness significant market share during forecast period.
• Based on Distribution, market is studied across Clinics, Hospital Pharmacy, Independent Pharmacy, and Online Platform. The Independent Pharmacy is projected to witness significant market share during forecast period.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Contraceptive Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Contraceptive Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Contraceptive Market, highlighting leading vendors and their innovative profiles. These include Abbvie Inc., Agile Therapeutics, Inc., Amneal Pharmaceuticals LLC, Aurobindo Pharma Limited, Bayer AG, Church & Dwight Co., Inc., CooperSurgical, Inc., Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., Merck & Co. Inc., Pfizer Inc., Reckitt Benckiser Group PLC, Teva Pharmaceuticals Industries Ltd., and Veru Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Contraceptive Market?
2. Which products, segments, applications, and areas hold the highest investment potential in the Contraceptive Market?
3. What is the competitive strategic window for identifying opportunities in the Contraceptive Market?
4. What are the latest technology trends and regulatory frameworks in the Contraceptive Market?
5. What is the market share of the leading vendors in the Contraceptive Market?
6. Which modes and strategic moves are suitable for entering the Contraceptive Market?

Note: PDF & Excel + Online Access - 1 Year